These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Outcomes of liver transplantation in 490 patients with hepatocellular carcinoma: validation of a uniform staging after surgical treatment. Vauthey JN; Ribero D; Abdalla EK; Jonas S; Bharat A; Schumacher G; Lerut J; Chapman WC; Hemming AW; Neuhaus P J Am Coll Surg; 2007 May; 204(5):1016-27; discussion 1027-8. PubMed ID: 17481532 [TBL] [Abstract][Full Text] [Related]
24. Glypican-3 immunocytochemistry in liver fine-needle aspirates : a novel stain to assist in the differentiation of benign and malignant liver lesions. Kandil D; Leiman G; Allegretta M; Trotman W; Pantanowitz L; Goulart R; Evans M Cancer; 2007 Oct; 111(5):316-22. PubMed ID: 17763368 [TBL] [Abstract][Full Text] [Related]
25. Predictors and prognostic significance of operative complications in patients with hepatocellular carcinoma who underwent hepatic resection. Kusano T; Sasaki A; Kai S; Endo Y; Iwaki K; Shibata K; Ohta M; Kitano S Eur J Surg Oncol; 2009 Nov; 35(11):1179-85. PubMed ID: 19443173 [TBL] [Abstract][Full Text] [Related]
26. Value of glypican 3 immunostaining in the diagnosis of hepatocellular carcinoma on needle biopsy. Anatelli F; Chuang ST; Yang XJ; Wang HL Am J Clin Pathol; 2008 Aug; 130(2):219-23. PubMed ID: 18628090 [TBL] [Abstract][Full Text] [Related]
27. [Laparoscopy and puncture biopsy in diagnosis of focal lesions of the liver]. Malinovskiĭ NN; Severtsev AN; Chudaev DB Khirurgiia (Mosk); 2004; (5):16-20. PubMed ID: 15159754 [TBL] [Abstract][Full Text] [Related]
28. Prognostic value of tumor-infiltrating FOXP3+ regulatory T cells in patients with hepatocellular carcinoma. Sasaki A; Tanaka F; Mimori K; Inoue H; Kai S; Shibata K; Ohta M; Kitano S; Mori M Eur J Surg Oncol; 2008 Feb; 34(2):173-9. PubMed ID: 17928188 [TBL] [Abstract][Full Text] [Related]
29. [The informative value of the criteria of cytological diagnostics of tumors of the thyroid gland]. Vorob'ev SL; Zaĭtseva IV; Matveeva ZS Vestn Khir Im I I Grek; 2007; 166(2):62-4. PubMed ID: 17665579 [TBL] [Abstract][Full Text] [Related]
31. Predictors of hepatic venous trunk invasion and prognostic factors in patients with hepatocellular carcinomas that had come into contact with the trunk of major hepatic veins. Matsuda M; Suzuki T; Kono H; Fujii H J Hepatobiliary Pancreat Surg; 2007; 14(3):289-96. PubMed ID: 17520205 [TBL] [Abstract][Full Text] [Related]
32. Predictors of survival after resection of early hepatocellular carcinoma. Nathan H; Schulick RD; Choti MA; Pawlik TM Ann Surg; 2009 May; 249(5):799-805. PubMed ID: 19387322 [TBL] [Abstract][Full Text] [Related]
33. Ultrasonographically and stereotactically guided fine-needle aspiration cytology of non-palpable breast lesions: cyto-histological correlation. Pogacnik A; Strojan Flezar M; Rener M Cytopathology; 2008 Oct; 19(5):303-10. PubMed ID: 17944953 [TBL] [Abstract][Full Text] [Related]
34. Serum C-reactive protein levels predict survival in hepatocellular carcinoma. Nagaoka S; Yoshida T; Akiyoshi J; Akiba J; Torimura T; Adachi H; Kurogi J; Tajiri N; Inoue K; Niizeki T; Koga H; Imaizumi T; Kojiro M; Sata M Liver Int; 2007 Oct; 27(8):1091-7. PubMed ID: 17845537 [TBL] [Abstract][Full Text] [Related]
35. [Cytological diagnosis of tumors and tumor-like formations of the neck in children]. Koriakina RF; Koroleva LS Lab Delo; 1984; (5):266-9. PubMed ID: 6204107 [No Abstract] [Full Text] [Related]
36. [Benign tumors of the liver]. Pollice L; Resta L; Russo S Pathologica; 1982; 74(1029):1-22. PubMed ID: 6283463 [No Abstract] [Full Text] [Related]
37. Surface enhanced laser desorption/ionization profiling: New diagnostic method of HBV-related hepatocellular carcinoma. Wu C; Wang Z; Liu L; Zhao P; Wang W; Yao D; Shi B; Lu J; Liao P; Yang Y; Zhu L J Gastroenterol Hepatol; 2009 Jan; 24(1):55-62. PubMed ID: 18823443 [TBL] [Abstract][Full Text] [Related]
39. Tumor-associated lymphangiogenesis correlates with prognosis after resection of human hepatocellular carcinoma. Thelen A; Jonas S; Benckert C; Weichert W; Schott E; Bötcher C; Dietz E; Wiedenmann B; Neuhaus P; Scholz A Ann Surg Oncol; 2009 May; 16(5):1222-30. PubMed ID: 19224279 [TBL] [Abstract][Full Text] [Related]
40. Development of a novel assay to quantify serum human telomerase reverse transcriptase messenger RNA and its significance as a tumor marker for hepatocellular carcinoma. Miura N; Maruyama S; Oyama K; Horie Y; Kohno M; Noma E; Sakaguchi S; Nagashima M; Kudo M; Kishimoto Y; Kawasaki H; Hasegawa J; Shiota G Oncology; 2007; 72 Suppl 1():45-51. PubMed ID: 18087181 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]